The FH Foundation Applauds UnitedHealthcare for Simplifying Prior Authorization for PCSK9 Inhibitors for Individuals with Familial Hypercholesterolemia

No Comments

Today, The FH Foundation, is pleased to recognize UnitedHealthcare for streamlining its prior authorization process and expanding access to PCSK9 inhibitors for familial hypercholesterolemia (FH). These changes are making it easier and faster for doctors and patients who qualify to get access to these … Read More